Stay updated with breaking news from Next Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sanford C. Bernstein started coverage on shares of Guardant Health (NASDAQ:GH – Free Report) in a report released on Thursday, Marketbeat reports. The brokerage issued an outperform rating and a $34.00 target price on the stock. Several other equities analysts have also recently commented on GH. William Blair reissued an outperform rating on shares of […]
Guardant Health (NASDAQ:GH – Get Free Report)‘s stock had its “buy” rating reissued by Citigroup in a research note issued on Monday, Benzinga reports. They currently have a $50.00 target price on the stock. Citigroup’s price target would suggest a potential upside of 72.24% from the company’s current price. Several other equities research analysts have […]
William Blair reiterated their outperform rating on shares of Guardant Health (NASDAQ:GH – Free Report) in a research report sent to investors on Friday, Marketbeat Ratings reports. Other equities analysts also recently issued research reports about the company. Citigroup boosted their target price on Guardant Health from $40.00 to $50.00 and gave the company a […]
Aristotle Atlantic Partners LLC raised its position in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 0.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 620,494 shares of the company’s stock after purchasing an additional 1,723 shares during the period. Aristotle Atlantic Partners LLC […]
Guardant Health (NASDAQ:GH – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at William Blair in a research note issued to investors on Friday, RTT News reports. Several other research firms also recently weighed in on GH. Citigroup upped their price objective on shares of Guardant Health from $40.00 to $50.00 […]